The stock of Cel-Sci Corp (CVM) has seen a -21.36% decrease in the past week, with a -32.72% drop in the past month, and a -42.65% decrease in the past quarter. The volatility ratio for the week is 9.42%, and the volatility levels for the past 30 days are at 6.14% for CVM. The simple moving average for the past 20 days is -21.94% for CVM’s stock, with a -52.55% simple moving average for the past 200 days.
Is It Worth Investing in Cel-Sci Corp (AMEX: CVM) Right Now?
Moreover, the 36-month beta value for CVM is 0.65. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CVM is 61.93M and currently, short sellers hold a 6.97% of that float. On November 08, 2024, CVM’s average trading volume was 296.76K shares.
CVM) stock’s latest price update
Cel-Sci Corp (AMEX: CVM)’s stock price has dropped by -7.92 in relation to previous closing price of 0.76. Nevertheless, the company has seen a loss of -21.36% in its stock price over the last five trading days. businesswire.com reported 2024-10-22 that VIENNA, Va.–(BUSINESS WIRE)—- $CVM #Multikine–FDA’s ODAC decision on checkpoint inhibitors substantiates potential of Multikine to address major treatment gap for PD-L1 negative cancer patients.
Analysts’ Opinion of CVM
Many brokerage firms have already submitted their reports for CVM stocks, with H.C. Wainwright repeating the rating for CVM by listing it as a “Buy.” The predicted price for CVM in the upcoming period, according to H.C. Wainwright is $18 based on the research report published on January 13, 2020 of the previous year 2020.
Dawson James, on the other hand, stated in their research note that they expect to see CVM reach a price target of $3. The rating they have provided for CVM stocks is “Buy” according to the report published on March 02nd, 2015.
CVM Trading at -31.11% from the 50-Day Moving Average
After a stumble in the market that brought CVM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.34% of loss for the given period.
Volatility was left at 6.14%, however, over the last 30 days, the volatility rate increased by 9.42%, as shares sank -30.72% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -35.81% lower at present.
During the last 5 trading sessions, CVM fell by -21.36%, which changed the moving average for the period of 200-days by -73.60% in comparison to the 20-day moving average, which settled at $0.8964. In addition, Cel-Sci Corp saw -74.28% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CVM starting from Watson Robert Eugene, who purchase 20,000 shares at the price of $1.39 back on May 08 ’24. After this action, Watson Robert Eugene now owns 24,431 shares of Cel-Sci Corp, valued at $27,800 using the latest closing price.
PRICHEP PATRICIA B, the Senior Vice President of Cel-Sci Corp, purchase 8,000 shares at $1.39 during a trade that took place back on May 08 ’24, which means that PRICHEP PATRICIA B is holding 232,326 shares at $11,120 based on the most recent closing price.
Stock Fundamentals for CVM
The total capital return value is set at -1.49. Equity return is now at value -244.53, with -100.88 for asset returns.
Based on Cel-Sci Corp (CVM), the company’s capital structure generated 0.59 points at debt to capital in total, while cash flow to debt ratio is standing at -1.57. The debt to equity ratio resting at 1.43. The interest coverage ratio of the stock is -36.79.
Currently, EBITDA for the company is -27.56 million with net debt to EBITDA at -0.5. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.64.
Conclusion
To wrap up, the performance of Cel-Sci Corp (CVM) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
